Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for CBSTQ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
September 30, 2025 -2.657M
June 30, 2025 1.342M
March 31, 2025 -3.429M
December 31, 2024 -1.960M
September 30, 2024 -2.240M
June 30, 2024 -16.93M
March 31, 2024 12.52M
December 31, 2023 -8.135M
September 30, 2023 -0.8039M
June 30, 2023 -3.090M
March 31, 2023 -2.037M
December 31, 2022 -1.318M
September 30, 2022 0.9935M
June 30, 2022 13.98M
Date Value
March 31, 2022 144.25M
December 31, 2021 18.05M
September 30, 2021 -10.76M
June 30, 2021 65.09M
March 31, 2021 129.02M
December 31, 2020 37.62M
September 30, 2020 0.5623M
June 30, 2020 35.64M
March 31, 2020 12.64M
December 31, 2019 1.803M
September 30, 2019 -3.137M
June 30, 2019 152.28M
March 31, 2019 0.00
December 31, 2018 85.43M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
cbdMD, Inc. -0.0597M
MedMen Enterprises, Inc. --
Australis Capital, Inc. --
ANI Pharmaceuticals, Inc. -4.647M
Corcept Therapeutics, Inc. -2.037M

Cash from Financing (Quarterly) Related Metrics